CHANGSA, China, Sept. 19 (UPI) -- The British pharmaceutical company GlaxoSmithKline was fined $487 million Friday after a bribery conviction in China.
The one-day secret trial in Changsa also convicted the company's former manager in China, Mark Reilly, and four other company managers. They received suspended sentences, and Reilly is expected to be deported.